b.weber@spiegel-institut.de

This page contains reports only for press releases paid for by using the email address as listed above. If multiple emails are used each address has its own reporting page. You can get reports for different emails over here.

(reports open in a new window)

Start [?] Press release Target Budget End [?] Reach Reads Social Report
21-Sep-22 12-month real-world achievements for Diabeloop’s Automated Insulin Delivery (AID): DK,SE-EN €1598 1-Oct-22 176,641+ 6,924 51,390+
2-Jun-22 Diabeloop, a key player in therapeutic AI applied to insulin delivery, announces 70 million euros new financing round to accelerate its international expansion DK-EN €799 12-Jun-22 81,672+ 1,746 27,383+
28-Apr-22 Diabeloop presents new real-life results of DBLG1® System: Confirmed improvement in Time In Range +18.4 percentage points; Reduction of time spent in hypoglycemia to only 0.9% DK-EN €799 8-May-22 75,587+ 1,529 22,594+
12-Apr-22 Diabeloop adapts its self-learning, personalized insulin automatization software to be used with insulin pens DK-EN €799 22-Apr-22 85,506+ 1,740 31,200+
28-Sep-21 Significant improvement in increasing Time In Range and reducing hypoglycemia among people equipped with Diabeloop DBLG1 GB,NL-EN €1598 8-Oct-21 210,932+ 6,226 64,490+
28-Sep-21 Significant improvement in increasing Time In Range and reducing hypoglycemia among people equipped with Diabeloop DBLG1 IT,ES-EN €1598 8-Oct-21 233,665+ 5,304 42,309+
2-Jun-21 De zelflerende algoritme DBLG1®: eenvoudig te gebruiken voor een optimale en gepersonaliseerde behandeling van diabetes type 1 NL,BE-NL €1398 12-Jun-21 139,352+ 3,361 37,219+

Should you have any questions about this account, please contact us at info@europawire.eu.

Thank you for releasing via EuropaWire.


Editorial Staff
EuropaWire